Document is current
Any future updates will be listed below
-
Authors
Siebenhaar, Frank
Nojarov, Nicole
Pyatilova, Polina
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 22 September 2025
Accepted: 27 November 2025
First Online: 19 December 2025
Conflict of interest
: F. Siebenhaar has received research funding from and/or is or has recently been a speaker/consultant for Allakos, Blueprint, Celldex, Cogent, Escient, GSK, Granular, Invea, Moxie, Noucor, Novartis, Sanofi/Regeneron, Telios, and Thirdharmonicbio. P. Pyatilova has received research funding from and/or is or has recently been a speaker/consultant for Blueprint, Celldex, and Granular. N. Nojarov declares that he has no competing interests.
